Consistent with these descriptions, it is reasonable to hypothesize cardiovascular complications following sepsis could be managed by modulating TLR signaling pathway and control the interaction of gram-negative bacteria LPS with cell surface receptors. This evidence concerns the gene CD177 and Sepsis.